70 likes | 89 Views
Tagrisso 40mg (osimertinib) tablet is containing an active substance known as Osimeritinib, which is formerly known as Mereletinib.Buy Tagrisso 40mg tablet @ Apple Pharmaceuticals
E N D
Tagrisso40mg tabletsAnti Cancer Treatment @myapplepharma
Tagrisso tablet • A Tagrisso 40 mg tablet is containing an active substance known as Osimeritinib, which is formerly known as Mereletinib. • The pharmacological category of Tagrisso 40mgis tyrosine kinaseprohibitor.
PRODUCT DETAILS • Brand Name :TagrissoComposition :OsimeritinibStrength availability : 40mg Manufactured by : AsterZenecaPack : 30 tablets in a carton
INDICATION • A Tagrisso 40mg (osimertinib) tablet is widely indicated as first line therapy for advanced non-small cell lung cancer with EGFR mutation positive patients. • Tagrisso40mgi s also used for the treatment of patients affected with advanced EGFR T792M mutation positive NSCLC, disease has advanced on or after the tyrosine kinase inhibitor treatment.
PRECAUTION Some of the adverse effects occur during the therapy :Interstitial lung disease: To avoid this problem, withheld or discontinue the Tagrisso 40mg tablets.QTc extension: Avoid concurrent use of Tagrisso 40mg with drug prolong the QTcCardiomyopathy: Periodic cardiac monitoring is assessed; in this condition discontinue the therapy.
SIDE EFFECTS • Common side effects :Fatigue, Lymphocytopenia (Low White Blood Cells),Low Sodium, Shortness of breath,Musculoskeletal Pain, Decreased Appetite, Cough Less common side effects :Constipation,Increasedserum creatinine, Colitis, Low potassium, Low magnesium, High calcium, Vomiting, Weakness
CONTACT US • Email id : info@myapplepharma.com • Phone no : 91-9987711567 • Website : https://myapplepharma.com/tagrisso-40mg.php